Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Gastrointestinal stromal cell tumor GIST.php on line 2
Gastrointestinal stromal cell tumor GIST
LE WE PMID CA
Gastrointestinal stromal cell tumor GIST963Gastrointestinaler Stromazelltumor

Arthritis (rheumatoid)

Bacillus calmette guerin

Bartonella henselae

Calcium (Hypercalciemia)

Candida (BASKET)

Carney s complex

Changes in terminology

Coccidioidomycosis

Crohn s disease

Cryptococcosis

Fat necrosis subcutaneous of the newborn

Gastrointestinal stromal cell tumor GIST

Histoplasmosis

Imatinib

Kidney (Neoplasm)

Langerhans cell histiocytosis

Lepra

Liver (Diseases)

Lung (Lipoid pneumonia)

Lung (Toxicology)

Lung and bronchial system (Neoplasia)

Lymphoma (BASKET)

Lymphoma (Hodgkin)

Menetrier s disease

Motesanib ttVEGF ttPDGF ttCD117

Mycobacterium avium

Neoplasia (Inherited)

Nervous system (Neoplasia Paraganglioma)

Neuroendocrine System (Neoplasia Carcinoid)

Osteoarthritis

Ovary (Neoplasia)

Paracoccoidomycosis

Pneumocystis carinii Pneumocystis jirovicii

Polymyositis

Pseudolymphoma (Lymphomatoid granulomatosis)

Pseudolymphoma (Plasma cell granuloma)

Sarcoidosis

Silicone

Slack skin disease

Sunitinib

Testis (Neoplasia Seminoma)

Testis (Neoplasia)

Tuberculosis

Wegener s granulomatosis

1969  
1
Sarcoma of the stomach: a review of 39 cases.
[4309300] South Med J 62(9): 1064-71 (1969)
2008  
2
Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate.
[18728705] Ther Clin Risk Manag 4(1): 149-62 (2008)
2007  
3
Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST).
[18360643] Ther Clin Risk Manag 3(2): 341-8 (2007)
2005  
4
Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.
[15985189] Health Technol Assess 9(25): 1-142 (2005)
2006  
5
Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment.
[16550259] Can J Gastroenterol 20(3): 157-63 (2006)
2009  
6
Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.
[19234649] Can J Surg 52(1): 31-8 (2009)
1998  
7
Gastrointestinal stromal tumours: an update.
[18521245] Sarcoma 2(3-4): 133-41 (1998)
2006  
8
Clinical presentation and treatment of gastrointestinal stromal tumors.
[17036516] Tumori 92(4): 279-84 (2006)
2008  
9
Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456761] Ann Oncol 19 Suppl 2(-): ii35-8 (2008)
2007  
10
Advances in the treatment of gastrointestinal stromal tumours.
[17761719] Ann Oncol 18 Suppl 10(-): x20-4 (2007)
2007  
11
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features.
[17591808] Ann Oncol 18 Suppl 6(-): vi136-40 (2007)
2006  
12
Gastrointestinal stromal tumor (GIST).
[17018739] Ann Oncol 17 Suppl 10(-): x280-6 (2006)
2005  
13
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
[15781488] Ann Oncol 16(4): 566-78 (2005)
2008  
14
Genetic aberrations of gastrointestinal stromal tumors.
[18671247] Cancer 113(7): 1532-43 (2008)
2005  
15
Gastrointestinal stromal tumor: 5 years later.
[16136600] Cancer 104(9): 1781-8 (2005)
2005  
16
Update on the biology and therapy of gastrointestinal stromal tumors.
[15668652] Cancer Control 12(1): 44-56 (2005)
2001  
17
Gastrointestinal stromal tumors.
[11378651] Cancer Control 8(3): 252-61 (2001)
2007  
18
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
[17332278] Clin Cancer Res 13(5): 1367-73 (2007)
2004  
19
Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST).
[14726714] Cancer Biol Ther 3(3): 251-8 (2004)
2003  
20
Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib.
[12704441] Pathol Oncol Res 9(1): 13-9 (2003)
2009  
21
Gastrointestinal stromal tumors: a 19 year experience.
[19432038] Isr Med Assoc J 11(2): 98-102 (2009)
2007  
22
Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach.
[17200708] J Clin Invest 117(1): 70-80 (2007)
2006  
23
An update on molecular genetics of gastrointestinal stromal tumours.
[16731599] J Clin Pathol 59(6): 557-63 (2006)
2009  
24
Current standards and progress in understanding and treatment of GIST.
[19234877] Swiss Med Wkly 139(7-8): 90-102 (2009)
2004  
25
Management of gastrointestinal stromal tumors: from diagnosis to treatment.
[15106018] Swiss Med Wkly 134(11-12): 145-53 (2004)
2006  
26
Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib.
[16549611] Radiographics 26(2): 481-95 (2006)
2003  
27
Gastrointestinal stromal tumors: radiologic features with pathologic correlation.
[12640147] Radiographics 23(2): 283-304, 456; quiz 532 (2003)
2010  
28
Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555113] Ann Oncol 21 Suppl 5(-): v98-102 (2010)
2010  
29
Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib.
[19675092] Ann Oncol 21(2): 208-15 (2010)
2009  
30
Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454466] Ann Oncol 20 Suppl 4(-): 64-7 (2009)
2010  
31
Molecular basis and management of gastrointestinal stromal tumors.
[20533592] World J Gastroenterol 16(22): 2726-34 (2010)
2010  
32
Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
[20427501] J Clin Endocrinol Metab 95(7): 3111-7 (2010)
2009  
33
Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors.
[19723753] J Clin Endocrinol Metab 94(10): 3656-62 (2009)
2010  
34
Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors.
[20200041] Oncologist 15(3): 300-7 (2010)
2010  
35
Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.
[20661913] Cancer 116(22): 5126-37 (2010)
2010  
36
The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor.
[20166214] Cancer 116(8): 1847-58 (2010)
2007  
37
A histopathological review of gastrointestinal related mesenchymal tumors: the hidden GIST.
[18085040] Isr Med Assoc J 9(11): 810-2 (2007)
2011  
38
Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation.
[21689502] Health Technol Assess 15(25): 1-178 (2011)
2010  
39
Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours.
[21047493] Health Technol Assess 14(Suppl. 2): 63-70 (2010)
2006  
40
2005  
41
The radiology of gastrointestinal stromal tumours (GIST).
[16361144] Cancer Imaging 5(-): 150-6 (2005)
2008  
42
Gastrointestinal stromal tumors: epidemiology, clinical picture, diagnosis, prognosis and treatment.
[18575421] Pol Arch Med Wewn 118(4): 216-21 (2008)
2009  
43
Gastrointestinal stromal tumors: a pictorial review.
[19795038] J Gastrointestin Liver Dis 18(3): 379-83 (2009)
2009  
44
Gastrointestinal stromal tumors: review on morphology, diagnosis and management.
[19690756] Rom J Morphol Embryol 50(3): 319-26 (2009)
2010  
45
Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment.
[20957137] Ther Clin Risk Manag 6(-): 453-8 (2010)
2007  
46
Gastro-intestinal stromal tumours: a review of current management options.
[17277393] Hong Kong Med J 13(1): 61-5 (2007)
2011  
47
Gastrointestinal stromal tumours treated before and after the advent of c-kit immunostaining.
[21524289] World J Surg Oncol 9(-): 44 (2011)
2011  
48
Gastrointestinal stromal tumors: molecular mechanisms and targeted therapies.
[21559207] Patholog Res Int 2011(-): 708596 (2011)
2009  
49
New therapeutic approaches for advanced gastrointestinal stromal tumors.
[19248977] Hematol Oncol Clin North Am 23(1): 139-50, x (2009)
2009  
50
Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population.
[19508837] Curr Oncol Rep 11(4): 314-21 (2009)
2008  
51
Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors.
[18516757] Curr Opin Investig Drugs 9(6): 576-82 (2008)
2008  
52
The role of adjuvant and neoadjuvant therapy in gastrointestinal stromal tumors.
[18525339] Curr Opin Oncol 20(4): 428-32 (2008)
2010  
53
Randomized clinical trials in gastrointestinal stromal tumors.
[19914562] Surg Oncol Clin N Am 19(1): 101-13 (2010)
2011  
54
Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors.
[20838998] Cancer Chemother Pharmacol 68(1): 69-77 (2011)
PMC   
55
Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.
[22892600] Am J Surg Pathol 37(1):114-9 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Gastrointestinal stromal cell tumor GIST.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Gastrointestinal stromal cell tumor GIST.php on line 92